Patents by Inventor Horst Klima

Horst Klima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170322225
    Abstract: Subject of the present invention are biomarkers and methods for the identification of risk for subsequent cardiovascular event (e.g. coronary heart disease death, non-fatal myocardial infarction, ischemic stroke, hospitalizations for unstable angina pectotis, cardiac arrest) in patients that have experienced an acute coronary syndrome, comprising the detecting the level of NT-proBNP, homocysteine and CRP.
    Type: Application
    Filed: April 21, 2017
    Publication date: November 9, 2017
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Thomas Dieterle, Eric J. Niesor, Rosemarie Kientsch-Engel, Horst Klima, Fabian Model, Gabriela Bucklar, Vinzent Rolny
  • Patent number: 7459429
    Abstract: The present invention relates to the use of erythropoietin for the treatment of disturbances of iron distribution in chronic inflammatory intestinal diseases.
    Type: Grant
    Filed: December 16, 2004
    Date of Patent: December 2, 2008
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Horst Klima, Paul Lehmann, Ralf Roeddiger, Ruth Walter-Matsui
  • Publication number: 20060105392
    Abstract: The invention concerns a method for determining vitamin B12, B6 or/and folic acid disorders and in particular the differential diagnosis of vitamin B12, vitamin B6 or/and folic acid disorders by means of three or four independent parameters. The differential diagnosis can be used to detect a vitamin B12, vitamin B6 or/and folic acid disorder and to recommend the required treatment and to monitor the course and success of treatment.
    Type: Application
    Filed: September 13, 2005
    Publication date: May 18, 2006
    Inventors: Paul Lehmann, Ralf Roddiger, Horst Klima
  • Publication number: 20050181986
    Abstract: The present invention relates to the use of erythropoietin for the treatment of disturbances of iron distribution in chronic inflammatory intestinal diseases.
    Type: Application
    Filed: December 16, 2004
    Publication date: August 18, 2005
    Inventors: Horst Klima, Paul Lehmann, Ralf Roeddiger, Ruth Walter-Matsui